Related Experiment Videos

Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly

B Swearingen1, F G Barker, L Katznelson

  • 1Neuroendocrine Clinical Center, Department of Surgery, Massachusetts General Hospital, and Harvard Medical School, Boston 02114, USA.

Summary

Multimodality therapy for acromegaly, including surgery, normalizes survival rates. Successful treatment significantly reduces mortality risk, indicating long-term efficacy of combined therapies for acromegaly patients.

Related Concept Videos